Current practice in Europe: how do we manage patients with ventricular tachycardia? European Heart Rhythm Association survey

Alessandro Proclemer*, Nikolaos Dagres, Germanas Marinskis, Laurent Pison, Gregory Y. H. Lip, Carina Blomstrom-Lundqvist

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

17 Citations (Web of Science)


The purpose of the EP wire is to examine the clinical practice in the management of sustained ventricular tachycardia (VT), with special focus on diagnostic and therapeutic strategies. Forty-five European centres, all members of the EHRA-EP Research network completed the questions of the survey. There was an equal distribution of centres with high, medium, and low volume of activity. The most common aetiologies were: post-myocardial infarction ischaemic heart disease (55), followed by idiopathic dilated cardiomyopathy (18), and idiopathic VT (11) and others (12). Cardiac magnetic resonance imaging was performed in more than 50 of patients in 24 centres (62.2). Invasive electrophysiological study was performed in more than 70 of patients in 16 centres (35.6), between 51 and 70 in 9 (20), below 50 in 20 (44.5). In 39 centres (86.7), implantable cardioverter defibrillator implantation was considered in all patients with structural heart disease and left ventricular ejection fraction 35. In the setting of secondary prevention, early radiofrequency ablation of the VT was performed in more than 50 of the patients in only five centres (11.4). Sequential endo-epicardial approach was reported in 52.2 of centres.
Original languageEnglish
Pages (from-to)167-169
JournalEP Europace
Issue number2
Publication statusPublished - Feb 2013


  • Ventricular tachycardia
  • EHRA survey

Cite this